Atea (AVIR) traded up 2.97 % during a 24 hours period ending at 10:14 AM Central Europe on Tuesday 27th. One Atea stock can currently be bought for about USD 4.16 on popular exchanges. Current supply of Atea stocks is 80.2 mn. Atea has a current market capitalization of USD 318.4 mn and approximately USD 1 mn worth of Atea was traded on exchanges in the last 24 hours. Since last month end, Atea has traded -20 % down. Simple moving average of last 200 days is at USD 4.92. The highest price of past 52 weeks was recorded at USD 6.45 on 03/10/2026. 52 weeks low was at USD 2.87 on 11/13/2025.

Here is how related stocks have performed in the past 24 hours:

  • Embecta (EMBC) traded up 1.34 % and now trades at USD 6.8. Embecta has a market capitalisation of USD 380.2 mn. Embecta has a current price to earnings ratio of 3.61.

  • Funko (FNKO) traded down -2.2 % and now trades at USD 6.68. Funko has a market capitalisation of USD 379.2 mn.

  • Cytodyn (CYDY) traded up 9.52 % and now trades at USD 0.24. Current market capitalisation for Cytodyn is USD 382.1 mn. CytoDyn Inc. reported updated data from its Phase 2 CLOVER study on leronlimab in patients with metastatic colorectal cancer at the ESMO Congress. The analysis highlighted consistent expression of the CCR5 target across all evaluated tumors and early reductions in circulating tumour DNA, indicating a promising biological response. Safety observations noted a favourable tolerability profile, with no significant drug‑related adverse events leading to discontinuation. The combination of leronlimab with established chemotherapy and bevacizumab appeared to enhance molecular residual disease reduction compared with the chemotherapy and bevacizumab alone. These findings support ongoing investigation of leronlimab’s role in modulating the tumour microenvironment and improving outcomes for patients with refractory disease.

  • Starz Entertainment (STRZ) traded down -5.77 % and now trades at USD 20.91. Current market capitalisation for Starz Entertainment is USD 380 mn.

  • Prelude Therapeutics (PRLD) traded up 1.93 % and now trades at USD 3.7. Prelude Therapeutics has a market capitalisation of USD 379.5 mn.

About Atea

Atea Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the discovery of oral direct-acting antiviral therapies. Based in Boston, Massachusetts, USA, the company serves patients, healthcare professionals, the pharmaceutical, and biotechnology industries globally through its website at www.ateapharma.com and trades on the Nasdaq stock exchange.